Propofol Attenuates Small Intestinal Ischemia Reperfusion Injury through Inhibiting NADPH Oxidase Mediated Mast Cell Activation

Figure 3

Changes of 15--isoprostane contents, SOD activities, p and gp protein expressions in intestine mucosa, and intestinal tryptase protein expression, and serum β-hexosaminidase levels in rats treated with NAC, propofol, and intralipid. (a) 15--isoprostane contents, (b) SOD activities, ((c)–(e)) intestinal p and gp9 protein expressions, (f) tryptase protein expression, and (g) β-hexosaminidase levels in normal saline pretreated group (NS), NAC pretreated group (NAC), propofol pretreated group (Pro), and intralipid pretreated group (Lip) (). Results are expressed as Mean ± SEM. versus NS.

(a)

(b)

(c)

(d)

(e)

(f)

(g)